Multiple Primary Cancers With Hematologic Malignancies and Germline Predisposition: A Case Series

被引:0
|
作者
Yun, Jiwon [1 ]
Lee, Dong Soon [2 ]
Lee, Sungyoung [3 ]
Yun, Hongseok [3 ]
机构
[1] Korea Univ, Anam Hosp, Coll Med, Dept Lab Med, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Dept Genom Med, 101 Daehak Ro, Seoul 03080, South Korea
基金
新加坡国家研究基金会;
关键词
Germline predisposition; Hematologic neoplasms; High-throughput nucleotide sequencing; Multiple primary neoplasms; MUTATIONS; GENES;
D O I
10.3343/alm.2023.0444
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The term "multiple primary (MP) cancers" refers to the existence of more than one cancer in the same patient. The combination of MP cancers with hematological malignancies is relatively uncommon. In this study, we present five patients diagnosed with MP cancers concomitant with hematological malignancies. We comprehensively analyzed their clinical characteristics, cytogenetic profiles, and germline and somatic variants. As first primaries, two patients had solid cancer not followed by cytotoxic therapy and three had hematologic cancer, followed by cytotoxic therapy. The second primaries were all hematologic malignancies that did not meet the criteria for therapy -related myeloid neoplasm. Notably, two (40%) out of the five patients harbored pathogenic potential/presumed germline variants in cancer predisposition genes. Therefore, germline variant testing should be considered when MP cancers with hematological malignancies require consideration for related donor stem cell transplantation.
引用
收藏
页码:446 / 449
页数:4
相关论文
共 50 条
  • [1] Genomic testing for germline predisposition to hematologic malignancies
    Hwang, Sang Mee
    BLOOD RESEARCH, 2024, 59 (01)
  • [2] Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies
    Himachandana Atluri
    Yoheved S. Gerstein
    Courtney D. DiNardo
    Current Hematologic Malignancy Reports, 2022, 17 : 275 - 285
  • [3] Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies
    Atluri, Himachandana
    Gerstein, Yoheved S.
    DiNardo, Courtney D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (06) : 275 - 285
  • [4] Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies
    Avagyan, Serine
    Shimamura, Akiko
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?
    Demko, Nadine
    Geyer, Julia T.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2024, 106 (05) : 331 - 346
  • [6] Fanconi Anemia Gene Associated Germline Predisposition in Aplastic Anemia and Hematologic Malignancies
    Nie, Daijing
    Wang, Fang
    Zhang, Jing
    Li, Xvxin
    Liu, Lili
    Zhang, Wei
    Cao, Panxiang
    Chen, Xue
    Zhang, Yang
    Chen, Jiaqi
    Zhou, Xiaosu
    Wu, Qisheng
    Liu, Hongxing
    BLOOD, 2020, 136
  • [7] Germline predisposition to hematopoietic malignancies
    Feurstein, Simone
    Drazer, Michael
    Godley, Lucy A.
    HUMAN MOLECULAR GENETICS, 2021, 30 (R2) : R225 - R235
  • [8] GERMLINE PREDISPOSITION TO HEMATOPOIETIC MALIGNANCIES
    Godley, Lucy
    EXPERIMENTAL HEMATOLOGY, 2021, 100 : S19 - S19
  • [9] Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies
    Daijing Nie
    Jing Zhang
    Fang Wang
    Xvxin Li
    Lili Liu
    Wei Zhang
    Panxiang Cao
    Xue Chen
    Yang Zhang
    Jiaqi Chen
    Xiaoli Ma
    Xiaosu Zhou
    Qisheng Wu
    Ming Liu
    Mingyue Liu
    Wenjun Tian
    Hongxing Liu
    Frontiers of Medicine, 2022, 16 : 459 - 466
  • [10] Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies
    Daijing Nie
    Jing Zhang
    Fang Wang
    Xvxin Li
    Lili Liu
    Wei Zhang
    Panxiang Cao
    Xue Chen
    Yang Zhang
    Jiaqi Chen
    Xiaoli Ma
    Xiaosu Zhou
    Qisheng Wu
    Ming Liu
    Mingyue Liu
    Wenjun Tian
    Hongxing Liu
    Frontiers of Medicine, 2022, 16 (03) : 459 - 466